Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

Nature Medicine

Volumn 4, Issue 3, 1998, Pages 354-357

  Poeschla, Eric M ^a   Wong Staal, Flossie ^a,b   Looney, David J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIFE CYCLE; MACROPHAGE; NERVE CELL CULTURE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

ANIMALS; CATS; CELLS, CULTURED; CYTOMEGALOVIRUS; GENES, IMMEDIATE-EARLY; GENETIC VECTORS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MACROPHAGES; NEURONS; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA-DIRECTED DNA POLYMERASE; SPECIES SPECIFICITY; TRANSFORMATION, GENETIC; VIRAL PROTEINS;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; UNGULATA;

EID: 0031953134     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0398-354     Document Type: Article

References (19)

1. Naldini, L. et al. In vivo gene delivery and stable transductton of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
2. Emerman, M. From curse to cure: HIV for gene therapy? Nature Biotechnol. 14, 943 (1996).
3. Pedersen, N.C., Ho, E.W., Brown, M.L & Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793 (1987).
4. Pedersen, N.C. The feline immunodeficiency virus. in The Retroviridae (ed. Levy, J.A.) 181-228 (Plenum Press, New York, 1993).
5. Elder, J.H. & Phillips, T.R. Molecular properties of feline immunodeficiency virus (FIV). Infect Agents Disease 2, 361-374 (1993).
6. Talbott, R.L. et al. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 5743-5747 (1989).
7. Olmsted, R.A., Hirsch, V.M., Purcell, R.H. & Johnson, P.R. Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses. Proc Natl. Acad. Sci. USA 86, 8088-8092 (1989).
8. Olmsted, R.A. et al. Worldwide prevalence of lentivirus infection in wild feline species: Epidemiologic and phylogenetic aspects. J. Viral. 66, 6008-6018 (1992).
9. Bachmann, M.H. et al. Genetic diversity of feline immunodeficiency virus: Dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J. Virol. 71, 4241-4253 (1997).
10. Tomonaga, K. et al. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J. Veterinary Med. Sci. 56, 199-201 (1994).
11. Miyazawa, T. et al. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone, J. Genl. Virol. 73, 1543-1546 (1992).
12. Sparger, E.E. et al. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187, 165-177 (1992).
13. Takeuchi, Y. et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68, 8001-8007 (1994).
14. Remington, K.M., Chesebro, B., Wehrly, K., Pedersen, N.C. & North, T.W. Mutants of feline immunodeficiency virus resistant to 3′-azido-3′-deoxythymidine. J. Virol. 65, 308-312 (1991).
15. Burns, J.C, Friedmann, T., Driever, W., Burrascano, M. & Yee, J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037 (1993).
16. Pleasure, S.J., Page, C. Sc Lee, V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12, 1802-1815 (1992).
17. Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825 (1995).
18. Willey, R.L. et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62, 139-147 (1988).
19. Kornbluth, R.S., Oh, P.S., Munis, J.R., Cleveland, P.H. & Richman, D.D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169, 1137-1151 (1989).